Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tobacco bill on the move

This article was originally published in The Tan Sheet

Executive Summary

The Senate June 4 debates House Energy and Commerce Chairman Henry Waxman's, D-Calif., Family Smoking Prevention and Tobacco Control Act, H.R. 1256, which would give FDA authority to regulate tobacco products. The Senate will consider Help, Education, Labor and Pensions Committee Chairman Ted Kennedy's, D-Mass., nearly identical bill, S. 982, on June 8. The House passed H.R. 1256 in April. If the Senate passes the House bill without amending it, that bill would be sent to the White House. However, if the Senate amends H.R. 1256 or passes S. 982 instead, the two chambers would appoint a conference committee to iron out differences. President Obama supports giving FDA authority over tobacco products (1"The Tan Sheet" May 25, 2009, p. 8)

You may also be interested in...



FDA Tobacco Authority Likely, But Foes Still Press That Agency Will Suffer

FDA regulation of tobacco appears imminent with a bill requiring the change headed to the Senate floor

GNC In Rough Seas From COVID-19 Pandemic; Vitamin Shoppe Safe In Port Under New Owner

GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.

QUOTED. 7 April 2020. Surendar Magar.

California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.

Topics

UsernamePublicRestriction

Register

PS103003

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel